Page last updated: 2024-10-27

fluorouracil and Li-Fraumeni Syndrome

fluorouracil has been researched along with Li-Fraumeni Syndrome in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Li-Fraumeni Syndrome: Rare autosomal dominant syndrome characterized by mesenchymal and epithelial neoplasms at multiple sites. MUTATION of the p53 tumor suppressor gene, a component of the DNA DAMAGE response pathway, apparently predisposes family members who inherit it to develop certain cancers. The spectrum of cancers in the syndrome was shown to include, in addition to BREAST CANCER and soft tissue sarcomas (SARCOMA); BRAIN TUMORS; OSTEOSARCOMA; LEUKEMIA; and ADRENOCORTICAL CARCINOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zerdoumi, Y1
Kasper, E1
Soubigou, F1
Adriouch, S1
Bougeard, G1
Frebourg, T1
Flaman, JM1

Other Studies

1 other study available for fluorouracil and Li-Fraumeni Syndrome

ArticleYear
A new genotoxicity assay based on p53 target gene induction.
    Mutation research. Genetic toxicology and environmental mutagenesis, 2015, Volume: 789-790

    Topics: Antineoplastic Agents; Cells, Cultured; Cisplatin; DNA Damage; Doxorubicin; Fluorouracil; Humans; Li

2015